首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 以基因为基之药物开发

市场调查报告书

商品编码

1820094

表观遗传学市场报告（按产品、技术、应用和地区）2025-2033

Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024 年全球表观遗传学市场规模达 27 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 78 亿美元，2025-2033 年期间的成长率 (CAGR) 为 12.02%。

表观遗传学是指研究活性和非活性基因表现中可遗传的变化。变化的来源可以是外部环境因素，也可以是内部因素，例如年龄和疾病。它通常用于诊断潜在疾病并防止其遗传给后代。它涉及各种酵素、仪器（例如测序仪、光谱仪和超音波仪）、试剂和试剂盒的使用。它们通常用于去氧核糖核酸 (DNA) 和组蛋白甲基化、非编码核糖核酸 (RNA)、乙酰化和磷酸化。因此，表观遗传学广泛应用于肿瘤、自体免疫、代谢、心血管和疼痛疾病的诊断、监测和治疗。

表观遗传学市场趋势：

全球癌症和自体免疫缺陷症候群（爱滋病）的日益普及是推动市场成长的关键因素之一。此外，表观遗传学解决方案在非肿瘤疾病治疗中的广泛应用也为市场成长提供了动力。突如其来的新冠肺炎疫情（COVID-19）也为市场参与者提供了成长机会。例如，各研究机构正在进行先进的表观遗传学测试，以研究病毒对人类基因组的影响，并正在开发用于早期识别、风险评估和个人化治疗的工具。此外，DNA和RNA修饰酶（例如乙酰化酶、甲基转移酶、逆转录酶和连接酶）的开发，以及高灵敏度和高选择性测试和仪器的推出，也起到了其他促进成长的因素作用。这些创新有助于评估基因组中位点特异性DNA甲基化。其他因素，包括生物技术领域的广泛研发活动，以及医疗保健基础设施的显着改善，尤其是在发展中经济体，预计将推动市场成长。

本报告回答的关键问题

全球表观遗传学市场有多大？ 2025-2033年全球表观遗传学市场的预期成长率是多少？
推动全球表观遗传学市场发展的关键因素有哪些？
COVID-19 对全球表观遗传学市场有何影响？
根据产品，全球表观遗传学市场如何分布？
根据技术，全球表观遗传学市场如何分布？
根据应用，全球表观遗传学市场如何分布？
全球表观遗传学市场的主要区域有哪些？
全球表观遗传学市场的主要参与者/公司有哪些？

Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.

Epigenetics Market Trends:

The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

Reagents
Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
Instruments
Enzymes
Services

Breakup by Technology:

DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures

Breakup by Application:

Oncology
- Solid Tumors
- Liquid Tumors
Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.

Key Questions Answered in This Report

1.How big is the global epigenetics market?
2.What is the expected growth rate of the global epigenetics market during 2025-2033?
3.What are the key factors driving the global epigenetics market?
4.What has been the impact of COVID-19 on the global epigenetics market?
5.What is the breakup of the global epigenetics market based on the product?
6.What is the breakup of the global epigenetics market based on the technology?
7.What is the breakup of the global epigenetics market based on the application?
8.What are the key regions in the global epigenetics market?
9.Who are the key players/companies in the global epigenetics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Epigenetics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Kits
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Chip Sequencing Kit
  - 6.2.2.2 Whole Genomic Amplification Kit
  - 6.2.2.3 Bisulfite Conversion Kit
  - 6.2.2.4 RNA Sequencing Kit
  - 6.2.2.5 Others
- 6.2.3 Market Forecast
6.3 Instruments
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Enzymes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Services
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Technology

7.1 DNA Methylation
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Histone Methylation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Histone Acetylation
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Large Non-Coding RNA
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 MicroRNA Modification
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Chromatin Structures
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Key Segments
  - 8.1.2.1 Solid Tumors
  - 8.1.2.2 Liquid Tumors
- 8.1.3 Market Forecast
8.2 Non-Oncology
- 8.2.1 Market Trends
- 8.2.2 Key Segments
  - 8.2.2.1 Inflammatory Diseases
  - 8.2.2.2 Metabolic Diseases
  - 8.2.2.3 Infectious Diseases
  - 8.2.2.4 Cardiovascular Diseases
  - 8.2.2.5 Others
- 8.2.3 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abcam plc
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Active Motif Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Agilent Technologies Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Diagenode Diagnostics (Hologic Inc)
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Illumina Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Merck KGaA
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 PerkinElmer Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Roche Holding AG
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Thermo Fisher Scientific Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Zymo Research Corporation
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio

简介目录图表

List of Figures

Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
Figure 2: Global: Epigenetics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2024
Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2024
Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2024
Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2024
Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: North America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: United States: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Canada: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: China: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Japan: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: India: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: South Korea: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Australia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Europe: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Germany: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: France: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Italy: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Spain: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Russia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Latin America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Brazil: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Mexico: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2024
Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Global: Epigenetics Industry: SWOT Analysis
Figure 84: Global: Epigenetics Industry: Value Chain Analysis
Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Epigenetics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Epigenetics Market: Competitive Structure
Table 7: Global: Epigenetics Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

表观遗传学市场报告（按产品、技术、应用和地区）2025-2033

Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033

表观遗传学市场趋势：

本报告回答的关键问题

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球表观遗传学市场

第六章：市场区隔：依产品

第七章：市场区隔：依技术

第 8 章：市场区隔：按应用

第九章：市场细分：依地区

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局